Adverse Reactions (6.1).] Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Rosiglitazone A total of 278 patients with type 2 diabetes participated in a 54-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin in combination with metformin and rosiglitazone
GLP-1-Rezeptor-Agonisten werden in der Regel subkutan gespritzt, im Bereich des Bauchs, des Oberschenkels oder des Oberarms
In the context of an animal model of TBI, it is possible to directly administer therapeutic agents to the cerebrospinal fluid (CSF) via an intraventricular pathway
Should I get my testosterone checked before starting semaglutide
$49/month, billed as $537 for 12-weeks recurring
Treatment of such an overdose would be mainly supportive, since there is no specific antagonist for B vitamin excess